August 9, 2022
Maruho on August 8 launched Mitchga (nemolizumab) for the treatment of itching associated with atopic dermatitis (AD). Discovered by Chugai Pharmaceutical, the drug is the world’s first antibody targeting IL-31 receptor A. In Japan, the drug was developed by Maruho...read more